David Zhang, Ph.D.

Co-founder and CEO

Biostate AI Pipeline

Drug	Indication	Phase
MARE DNAseq for Newborn Screening	5,000+ Inherited Genetic Diseases	Development
RNAseq (BIRT+PERD) Platform	Broad Transcriptomic Analysis for Disease Prediction	Development/Service
AML (N-Act) AI	Acute Myeloid Leukemia	Development
K-Dense Autonomous Research	Broad Scientific Discovery	Research